Acorah Software Products - Accounts Production15.0.600falsetruefalsetrueNo description of principal activity1 February 202331 January 202431 January 202414597255Mr Haitham MahdiDr Samar Azazyiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure145972552023-01-31145972552024-01-31145972552023-02-012024-01-3114597255frs-core:CurrentFinancialInstruments2024-01-3114597255frs-bus:PrivateLimitedCompanyLtd2023-02-012024-01-3114597255frs-bus:FilletedAccounts2023-02-012024-01-3114597255frs-bus:Micro-entities2023-02-012024-01-3114597255frs-bus:AuditExempt-NoAccountantsReport2023-02-012024-01-3114597255frs-bus:Director12023-02-012024-01-3114597255frs-bus:Director22023-02-012024-01-31
Registered number: 14597255
Sahm Medics Ltd
Financial Statements
For The Year Ended 31 January 2024
Charles & Co.
Sahm Medics Ltd
Balance Sheet
As At 31 January 2024
Balance Sheet
Registered number: 14597255
2024
£
Current assets
2,311
Creditors: Amounts Falling Due Within One Year
(1,212)
NET CURRENT ASSETS
1,099
TOTAL ASSETS LESS CURRENT LIABILITIES
1,099
Accruals and deferred income
(950)
NET ASSETS
149
CAPITAL AND RESERVES
149
Notes
1.General Information
Sahm Medics Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14597255. The registered office is 21 Manor Road, Sale, M33 7FL.
2.Average Number of Employees
Average number of employees, including directors, during the year was: 2
2
For the year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.